Advisor Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-452
| Closed | -$2K | – | 5443 |
|
|
2019
Q3 | $2K | Buy |
452
+439
| +3,377% | +$1.94K | ﹤0.01% | 5010 |
|
|
2019
Q2 | $0 | Buy |
+13
| New | – | ﹤0.01% | 5436 |
|
|
2018
Q3 | – | Sell |
-502
| Closed | -$8K | – | 5280 |
|
|
2018
Q2 | $8K | Sell |
502
-6
| -1% | -$96 | ﹤0.01% | 4197 |
|
|
2018
Q1 | $9K | Buy |
508
+260
| +105% | +$4.61K | ﹤0.01% | 4163 |
|
|
2017
Q4 | $5K | Hold |
248
| – | – | ﹤0.01% | 4433 |
|
|
2017
Q3 | $10K | Sell |
248
-43
| -15% | -$1.73K | ﹤0.01% | 3996 |
|
|
2017
Q2 | $9K | Buy |
291
+76
| +35% | +$2.35K | ﹤0.01% | 4005 |
|
|
2017
Q1 | $8K | Buy |
215
+29
| +16% | +$1.08K | ﹤0.01% | 3930 |
|
|
2016
Q4 | $9K | Hold |
186
| – | – | ﹤0.01% | 3685 |
|
|
2016
Q3 | $10K | Buy |
186
+39
| +27% | +$2.1K | ﹤0.01% | 3572 |
|
|
2016
Q2 | $6K | Buy |
+147
| New | +$6K | ﹤0.01% | 3723 |
|